Dearborn Partners LLC Merck & Co., Inc. Transaction History

Dearborn Partners LLC

$2.42 Billion
Q3 2024

A detailed history of Dearborn Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dearborn Partners LLC holds 284,419 shares of MRK stock, worth $27.9 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares

284,419

Previous 290,989 2.26%

Holding current value

$27.9 Million

Previous $36 Million 10.34%

% of portfolio

1.34%

Previous 1.58%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$111.15 - $128.97 $730,255 - $847,332	-6,570 Reduced 2.26%	284,419 $32.3 Million
Q2 2024 Jul 26, 2024	SELL	$123.8 - $132.96 $323,241 - $347,158	-2,611 Reduced 0.89%	290,989 $36 Million
Q1 2024 May 08, 2024	SELL	$113.24 - $131.95 $12.3 Million - $14.4 Million	-108,768 Reduced 27.03%	293,600 $38.7 Million
Q4 2023 Jan 26, 2024	SELL	$100.18 - $109.02 $856,138 - $931,684	-8,546 Reduced 2.08%	402,368 $43.9 Million
Q3 2023 Nov 01, 2023	BUY	$102.95 - $114.33 $102,126 - $113,415	992 Added 0.24%	410,914 $42.3 Million
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $10.7 Million - $11.7 Million	-98,752 Reduced 19.41%	409,922 $47.3 Million
Q1 2023 May 04, 2023	BUY	$102.94 - $114.86 $88,116 - $98,320	856 Added 0.17%	508,674 $54.1 Million
Q4 2022 Feb 02, 2023	SELL	$87.44 - $112.11 $405,459 - $519,854	-4,637 Reduced 0.9%	507,818 $56.3 Million
Q3 2022 Oct 25, 2022	BUY	$84.53 - $94.96 $180,048 - $202,264	2,130 Added 0.42%	512,455 $44.1 Million
Q2 2022 Jul 20, 2022	SELL	$83.49 - $94.64 $138,843 - $157,386	-1,663 Reduced 0.32%	510,325 $46.5 Million
Q1 2022 May 04, 2022	BUY	$73.51 - $82.4 $1.05 Million - $1.18 Million	14,283 Added 2.87%	511,988 $42 Million
Q4 2021 Jan 28, 2022	BUY	$72.28 - $90.54 $222,333 - $278,501	3,076 Added 0.62%	497,705 $38.1 Million
Q3 2021 Oct 27, 2021	BUY	$71.68 - $78.83 $13.4 Million - $14.8 Million	187,443 Added 61.02%	494,629 $37.2 Million
Q2 2021 Jul 26, 2021	SELL	$70.31 - $77.77 $21.5 Million - $23.8 Million	-306,057 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$68.86 - $81.11 $407,995 - $480,576	5,925 Added 1.97%	306,057 $23.6 Million
Q4 2020 Jan 27, 2021	BUY	$71.77 - $79.65 $267,486 - $296,855	3,727 Added 1.26%	300,132 $24.6 Million
Q3 2020 Oct 20, 2020	BUY	$73.18 - $82.95 $76,839 - $87,097	1,050 Added 0.36%	296,405 $24.6 Million
Q2 2020 Jul 30, 2020	SELL	$70.42 - $80.13 $527,164 - $599,853	-7,486 Reduced 2.47%	295,355 $22.8 Million
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $551,675 - $764,648	8,707 Added 2.96%	302,841 $23.3 Million
Q4 2019 Jan 28, 2020	BUY	$77.58 - $87.54 $1.3 Million - $1.47 Million	16,751 Added 6.04%	294,134 $26.8 Million
Q3 2019 Oct 29, 2019	BUY	$76.08 - $82.93 $317,710 - $346,315	4,176 Added 1.53%	277,383 $23.4 Million
Q2 2019 Jul 29, 2019	BUY	$69.84 - $81.59 $691,555 - $807,904	9,902 Added 3.76%	273,207 $22.9 Million
Q1 2019 May 01, 2019	BUY	$69.58 - $79.36 $420,819 - $479,969	6,048 Added 2.35%	263,305 $21.9 Million
Q4 2018 Feb 04, 2019	BUY	$65.24 - $75.71 $205,049 - $237,956	3,143 Added 1.24%	257,257 $19.7 Million
Q3 2018 Oct 24, 2018	BUY	$57.69 - $67.84 $161,589 - $190,019	2,801 Added 1.11%	254,114 $18 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $660,078 - $775,523	-12,986 Reduced 4.91%	251,313 $15.3 Million
Q1 2018 May 01, 2018	SELL	$50.96 - $59.23 $448,142 - $520,868	-8,794 Reduced 3.22%	264,299 $14.4 Million
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $442,693 - $528,624	-8,576 Reduced 3.04%	273,093 $15.4 Million
Q3 2017 Nov 13, 2017	SELL	$58.67 - $63.13 $34,732 - $37,372	-592 Reduced 0.21%	281,669 $18 Million
Q2 2017 Aug 09, 2017	BUY	N/A	282,261	282,261 $18.1 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Account

Dearborn Partners LLC Merck & Co., Inc. Transaction History